BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cytochrome P 450 Cyp3a

A cytochrome P-450 suptype that has specificity for a broad variety of lipophilic compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN.

26+ PubMed studies analyzed · Evidence Score: 42.6

Research Domains

Cytochrome P 450 Cyp3a has been studied across 11 research domains including 🫁 Liver & Detox, ❤️ Cardiovascular, 🛡️ Immunity, ⚡ Energy & Fatigue, 🧠 Focus & Attention. The primary research focus is 🫁 Liver & Detox with 42% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cytochrome P 450 Cyp3a is generated deterministically from 26 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.